Annual Current Liabilities
$25.11 M
+$1.41 M+5.97%
December 31, 2023
Summary
- As of March 1, 2025, NMRA annual total current liabilities is $25.11 million, with the most recent change of +$1.41 million (+5.97%) on December 31, 2023.
- During the last 3 years, NMRA annual current liabilities has risen by +$15.74 million (+167.99%).
- NMRA annual current liabilities is now at all-time high.
Performance
NMRA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$31.74 M
+$8.62 M+37.27%
September 30, 2024
Summary
- As of March 1, 2025, NMRA quarterly total current liabilities is $31.74 million, with the most recent change of +$8.62 million (+37.27%) on September 30, 2024.
- Over the past year, NMRA quarterly current liabilities has increased by +$7.13 million (+28.99%).
- NMRA quarterly current liabilities is now at all-time high.
Performance
NMRA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NMRA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.0% | +29.0% |
| 3 y3 years | +168.0% | +38.9% |
| 5 y5 years | +10000.0% | +38.9% |
NMRA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.9% | at high | +77.1% |
| 5 y | 5-year | at high | >+9999.0% | at high | +238.8% |
| alltime | all time | at high | >+9999.0% | at high | +238.8% |
Neumora Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.74 M(+37.3%) |
| Jun 2024 | - | $23.13 M(-6.0%) |
| Mar 2024 | - | $24.61 M(-2.0%) |
| Dec 2023 | $25.11 M(+6.0%) | $25.11 M(-13.8%) |
| Sep 2023 | - | $29.12 M(+11.6%) |
| Jun 2023 | - | $26.09 M(+10.1%) |
| Dec 2022 | $23.70 M | $23.70 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $22.86 M(+27.5%) |
| Mar 2022 | - | $17.93 M(-23.0%) |
| Dec 2021 | $23.28 M(+148.4%) | - |
| Dec 2021 | - | $23.28 M(+11.1%) |
| Sep 2021 | - | $20.95 M(+123.6%) |
| Dec 2020 | $9.37 M(>+9900.0%) | $9.37 M |
| Dec 2019 | $21.00 K | - |
FAQ
- What is Neumora Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics annual current liabilities year-on-year change?
- What is Neumora Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly current liabilities year-on-year change?
What is Neumora Therapeutics annual total current liabilities?
The current annual current liabilities of NMRA is $25.11 M
What is the all time high annual current liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high annual total current liabilities is $25.11 M
What is Neumora Therapeutics annual current liabilities year-on-year change?
Over the past year, NMRA annual total current liabilities has changed by +$1.41 M (+5.97%)
What is Neumora Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NMRA is $31.74 M
What is the all time high quarterly current liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly total current liabilities is $31.74 M
What is Neumora Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NMRA quarterly total current liabilities has changed by +$7.13 M (+28.99%)